A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus

• Status: Completed
• Trial end date: 2014-12-01

Summary

There is a need to find an effective therapy for diabetic patients who develop macular edema after cataract surgery.

• Phase: Phase 2

Details

• Lead Sponsor: Retinal Consultants of Arizona
• Collaborator: Allergan
• Treatments: BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate; Ophthalmic Solutions; Prednisolone acetate; Tetrahydrozoline